Source: Annual Congress 2013 –COPD: new markers of diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. H. Wang, T. T. Huang, H. P. Kuo (Taipei, Taiwan). Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease. Eur Respir J 2013; 42: Suppl. 57, 602

Member's Comments

No comment yet.

Related content which might interest you: Survivin in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Characterisation of defective phagocytosis by chronic obstructive pulmonary disease alveolar macrophages Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Dysregulation of serum miRNA in chronic obstructive pulmonary disease Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015 Increased vimentin expression in human primary bronchial epithelium reconstituted in vitro from patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Recruitment of blood fibrocytes during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4 dependent pathway Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Endotelialny dysfunction at patients with COPD and coronary heart disease Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Neutrophil numbers are decreased in bronchial biopsies from patients with COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 T-cell pathways in lung tissue of patients with advanced COPD and IPF requiring lung transplantation Source: International Congress 2016 – Mechanisms of disease Year: 2016 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Cardiac troponin T levels increase overnight in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013